Last viewed: PLRX


Prices are updated after-hours



nasdaq:PLRX Pliant Therapeutics, Inc.

PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (64.0% 1m) (176.0% 1y) (0.0% 2d) (-2.3% 3d) (-4.9% 7d) (Infinity% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 1,547,623,959

http://www.pliantrx.com
Sec Filling | Patents | 62 employees


(US) Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.



add to watch list email alert is off

Press-releases


Pliant Therapeutics to Participate in Upcoming Investor Events
Published: 2023-02-07 (Crawled : 14:00) - biospace.com/
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: -2.67% H: 0.0% C: 0.0%

therapeutics
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 2.42% C: -1.93%

pln-1010 treatment fda clearance drug for therapeutics tumors
Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-01-27 (Crawled : 22:00) - globenewswire.com
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

offering therapeutics
Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
JNJ | $163.61 0.13% 0.24% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.0% C: 0.0%
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: 4.99% H: 0.0% C: 0.0%

therapeutics
Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering
Published: 2023-01-25 (Crawled : 03:00) - globenewswire.com
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: 4.99% H: 0.0% C: 0.0%

offering therapeutics
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
Published: 2023-01-22 (Crawled : 20:20) - globenewswire.com
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: 58.7% H: 4.17% C: -13.58%

fibrosis trial therapeutics positive phase 2b
Pliant Therapeutics Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2022-12-15 (Crawled : 21:00) - biospace.com/
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: -1.72% H: 3.29% C: 3.02%

pln-7480 treatment fibrosis designation for therapeutics
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published: 2022-11-15 (Crawled : 13:00) - globenewswire.com
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: 3.37% H: 5.71% C: 3.14%

therapeutics
Pliant Therapeutics Announces Appointment of Katharine Knobil, M.D. to Board of Directors
Published: 2022-09-15 (Crawled : 14:00) - biospace.com/
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: -1.4% H: 0.96% C: -0.04%

therapeutics
Pliant Therapeutics Announces Positive DSMB Safety Review of INTEGRIS-IPF Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Published: 2022-09-01 (Crawled : 14:20) - biospace.com/
PLRX M | $31.74 -1.67% -1.73% 310K twitter stocktwits trandingview |
Health Technology
| | O: 1.76% H: 4.84% C: 3.47%

pln-7480 fibrosis trial therapeutics review positive phase 2b
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001140361-23-004735 4 2023-02-06 2023-02-03 Sell M 15000 327262
0001140361-23-004735 4 2023-02-06 2023-02-02 Sell M 15000 342262
0001140361-23-004735 4 2023-02-06 2023-02-03 Sell S 9738 245374
0001140361-23-004735 4 2023-02-06 2023-02-02 Sell S 1605 240112
0001140361-23-004735 4 2023-02-06 2023-02-02 Sell S 13395 241717
0001140361-23-004735 4 2023-02-06 2023-02-02 Buy M 15000 255112
0001140361-23-003977 4 2023-02-02 2023-02-01 Sell M 15000 357262
0001140361-23-003977 4 2023-02-02 2023-01-31 Sell M 4461 372262
0001140361-23-003977 4 2023-02-02 2023-01-31 Sell M 10539 146841
0001140361-23-003977 4 2023-02-02 2023-01-30 Sell M 15000 157380
0001140361-23-003977 4 2023-02-02 2023-02-01 Sell S 5440 240217
0001140361-23-003977 4 2023-02-02 2023-02-01 Sell S 9455 245657
0001140361-23-003977 4 2023-02-02 2023-01-31 Buy M 10539 250651
0001140361-23-003977 4 2023-02-02 2023-01-30 Sell S 3605 240112
0001140361-23-003977 4 2023-02-02 2023-01-30 Sell S 11395 243717
0001140361-23-003977 4 2023-02-02 2023-01-30 Buy M 15000 255112
0001140361-23-003181 4 2023-01-28 2023-01-25 Buy A 76200 76200
0001140361-23-003181 4 2023-01-28 2023-01-25 Buy A 54000 138424
0001140361-23-003180 4 2023-01-28 2023-01-25 Buy A 76200 76200
0001140361-23-003180 4 2023-01-28 2023-01-25 Buy A 54000 192191
0001140361-23-003179 4 2023-01-28 2023-01-25 Buy A 55000 55000
0001140361-23-003179 4 2023-01-28 2023-01-25 Buy A 39000 44947


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
57% 43%

Top 10 Gainers
CZOO | $0.2001 -16.63% 1874.01% 3.3M twitter stocktwits trandingview |

AVRO | $1.69 93.7% 54.08% 38M twitter stocktwits trandingview |
Health Technology

CELZ | $1.04 101.04% 50.26% 140M twitter stocktwits trandingview |

WETG | $0.65 58.54% 37.88% 27M twitter stocktwits trandingview |

GFAI | $0.5408 58.36% 36.88% 89M twitter stocktwits trandingview |

KPRX | $6.94 52.53% 34.15% 36M twitter stocktwits trandingview |
Manufacturing

PRFX | $0.7236 44.72% 30.07% 14M twitter stocktwits trandingview |
Health Technology

BJDX | $0.64 37.16% 23.51% 2.8M twitter stocktwits trandingview |

SOUN 4 | $4.63 28.61% 22.08% 62M twitter stocktwits trandingview |

THCH | $5.3 26.19% 19.69% 750K twitter stocktwits trandingview |
n/a


Last 48 Hours Insiders Buying
PMT P 10340 | $14.42 0.35% -0.07% 730K twitter stocktwits trandingview |
Finance
| 01:30
APPN P 50000 | $42.79 -1.45% -1.47% 300K twitter stocktwits trandingview |
Technology Services
| 23:30
BOKF P 1000 | $103.18 -1.45% -1.37% 110K twitter stocktwits trandingview |
Finance
| 23:00
IVAC P 15000 | $7.08 1.87% 1.7% 920K twitter stocktwits trandingview |
Electronic Technology
| 22:30
FKYS P 599 | $21.75 0.37% 700 twitter stocktwits trandingview |
Finance and Insurance
| 22:20
ASRV P 1884 | $4.015 0.38% 0.74% 4.2K twitter stocktwits trandingview |
Finance
| 19:40
RILY P 20000 | $39.6 -10.2% -13.05% 2M twitter stocktwits trandingview |
Finance
| 19:40
BSGM P 349323 | $1.17 2.63% 2.56% 260K twitter stocktwits trandingview |
Health Technology
| 17:30
HPKEW 4 | $16.0 0% twitter stocktwits trandingview |
Industrial Services
| 23:50

12 months watchlist earnings calendar